FULL PAPER
6(H2O) (168 mg, 0.50 mmol) and ascorbic acid (20 mg) were dis-
Acknowledgments
solved in MeOH (3 mL). The two solutions were combined drop-
wise and a white precipitate immediately formed. The precipitate
was collected by filtration and washed with MeOH. Mw 794.01;
We thank the Australian Research Council for providing an Austra-
lian Research Fellowship to S. M. N. and Discovery Grants to
S. M. N and K. S. M. to support this work. The help provided by
Nicholas Chilton in fitting the magnetic data for 7 and 8 by use of
his program PHI is gratefully acknowledged.
yield 311 mg (78.33%); IR: ν = 3130 (s), 2081 (w), 1627 (s), 1586
˜
(s), 1532 (s), 1449 (s), 1396 (m), 1337 (m), 1301 (m), 1189 (s), 1080
(s), 988 (s), 889 (m), 751 (s), 689 (m), 623 (s) cm–1.
C33H30N12Fe1B2F8: calcd. C 48.09, H 3.67, N 20.39; found C 49.09,
H 4.04, N 20.76.
[FeII(Hcintrz)3](ClO4)2·1.5(H2O) (5): Hcintrz (300 mg, 1.5 mmol)
was dissolved in MeOH (20 mL). Separately Fe(ClO4)2·6(H2O)
(128 mg, 0.50 mmol) and ascorbic acid (20 mg) were dissolved in
MeOH (3 mL). The two solutions were combined dropwise and
an off-white precipitate immediately formed. The precipitate was
collected by filtration and washed with MeOH. Mw 849.42; yield
[1] P. Gütlich, H. A. Goodwin, Top. Curr. Chem. 2004, 233, 1.
[2] O. Kahn, C. J. Martinez, Science 1998, 279, 44.
[3] Y. Garcia, V. Niel, M. Carmen Munoz, J. A. Real, Top. Curr.
Chem. 2004, 233, 229.
[4] J. G. Haasnoot, Coord. Chem. Rev. 2000, 200–202, 131.
[5] P. J. v. Koningsbruggen, Top. Curr. Chem. 2004, 233, 123.
[6] A. Grosjean, N. Daro, B. Kauffmann, A. Kaiba, J.-F. Létard,
P. Guionneau, Chem. Commun. 2011, 47, 12382.
424 mg (51.3%); IR: ν = 3112 (s), 1627 (s), 1586 (s), 1531 (s), 1449
˜
[7] M. M. Dirtu, C. Neuhausen, A. D. Naik, A. Rotaru, L. Spinu,
Y. Garcia, Inorg. Chem. 2010, 49, 5723.
(m), 1395 (m), 1337 (m), 1188 (s), 1082 (s), 1054 (s), 989 (s), 750
(s), 688 (s), 620 (s) cm–1. C33H30Fe1N12O8Cl2: calcd. C 46.66, H
3.56, N 19.79; found C 46.45, H 3.70, N 19.45.
[8] A. Bousseksou, G. Molnar, L. Salmon, W. Nicolazzi, Chem.
Soc. Rev. 2011, 40, 3313; I. Boldog, A. B. Gaspar, V. Martínez,
P. Pardo-Ibañez, V. Ksenofontov, A. Bhattacharjee, P. Gütlich,
J. A. Real, Angew. Chem. 2008, 120, 6533; Angew. Chem. Int.
Ed. 2008, 47, 6433; L. Catala, D. Brinzei, Y. Prado, A. Gloter,
O. Stéphan, G. Rogez, T. Mallah, Angew. Chem. 2008, 120, 1;
Angew. Chem. Int. Ed. 2008, 47, 1; E. Coronado, J. R. Galán-
Mascarós, M. Monrabal-Capilla, J. García-Martinez, P. Pardo-
Ibáñez, Adv. Mater. 2007, 19, 1359; T. Forestier, S. Mornet, N.
Daro, T. Nishihara, S.-I. Mouri, K. Tanaka, O. Fouché, E. Fre-
ysz, J.-F. Létard, Chem. Commun. 2008, 4327; S. M. Neville, C.
Etrillard, S. Asthana, J.-F. Létard, Eur. J. Inorg. Chem. 2010,
282.
[FeII(Hcintrz)3](Br)2·1.5(H2O) (6): Hcintrz ligand (300 mg,
1.5 mmol) was dissolved in MeOH (20 mL). Separately FeBr2
(100 mg, 0.50 mmol) and ascorbic acid (20 mg) were dissolved in
MeOH (3 mL). The two solutions were combined dropwise and a
white precipitate immediately formed. The precipitate was collected
by filtration and washed with MeOH. Mw 810.32; yield 333 mg
(82.1%); IR: ν = 2959 (s), 1649 (sh), 1626 (s), 1584 (s), 1529 (s),
˜
1448 (m), 1317 (w), 1188 (s), 1074 (s), 990 (s), 750 (s), 688 (s),
620 (s) cm–1. C33H30N12 Fe1Br2 + 5H2O (solvent not included in
formula): calcd. C 44.02, H 4.48, N 18.67; found C 43.94, H 3.88,
N 17.91
[9] T. Fujigaya, D.-L. Jiang, T. Aida, J. Am. Chem. Soc. 2005, 127,
5484.
[10] P. Grondin, D. Siretanu, O. Roubeau, M.-F. Achard, R. Clerac,
Inorg. Chem. 2012, 51, 5417.
Attempts to form crystals of the 1D chain materials [Fe(Xtrz)3](A)2·
nH2O by slow evaporation, slow diffusion and solvothermal meth-
ods were unsuccessful; in each case polycrystalline samples were
produced. However, when using A = NCS– or NCSe/ClO4– crystals
of the formula [Fe2(Hsaltrz)5(NCS)4]·4(H2O) (7) and [Fe3(Hsaltrz)6-
(H2O)2(EtOH)4](ClO4)6 (8) were obtained by slow diffusion. An
isostructural cobalt(II) analogue of 7, [Co2(Hsaltrz)5(NCS)4]·H2O
has been previously reported but differs in its degree of hy-
dration.[31] Additionally, an isomorph of 7 was recently reported,[19]
[Fe2(Hsaltrz)5(NCS)4]·4 MeOH, differing in the solvent.
[11] L. G. Lavrenova, V. N. Ikorski, V. A. Varnek, I. M. Oglezneva,
S. V. Larionov, Koord. Khim. 1986, 12, 207; O. Roubeau, J. M.
Alcazar-Gómez, E. Balskus, J. J. A. Kolnaar, J. G. Haasnoot, J.
Reedijk, New J. Chem. 2001, 25, 144; Y. Garcia, P. J. van Kon-
ingsbruggen, P. Lapouyade, L. Rabardel, O. Kahn, M. Wier-
czorek, R. Bronisz, Z. Ciunik, M. F. Rudolf, C. R. Acad. Sci.
Paris IIc 1998, 1, 523; Y. Garcia, P. J. van Koningsbruggen, R.
Lapouyade, L. Fournès, L. L. Rabardel, O. Kahn, V. Kseno-
fontov, G. Levchenko, P. Gütlich, Chem. Mater. 1998, 10, 2426.
[12] M. Seredyuk, A. B. Gaspar, M. C. Muñoz, M. Verdaguer, F.
Villain, P. Gütlich, Eur. J. Inorg. Chem. 2007, 4481.
[13] Y. Wei, P. Sonar, M. Grunert, J. Kusz, A. D. Schlüter, P.
Gütlich, Eur. J. Inorg. Chem. 2010, 3930.
[14] Y. Garcia, P. Guionneau, G. Bravic, D. Chasseau, J. A. K.
Howard, O. Kahn, V. Ksenofontov, S. Reiman, P. Gütlich, Eur.
J. Inorg. Chem. 2000, 1531.
[15] N. F. Chilton, PHI Computer Program, unpublished 2012.
[16] D. Savard, C. Cook, G. D. Enright, I. Korobkov, T. J. Burch-
ella, M. Murugesu, CrystEngComm 2011, 13, 5190.
[17] M. Thomann, O. Kahn, J. Guilhem, F. Varret, Inorg. Chem.
1994, 33, 6029.
[18] G. Vos, R. A. G. de Graaff, J. G. Haasnoot, A. M.
van der Kraan, P. de Vaal, J. Reedijk, Inorg. Chem. 1984, 23,
2905; G. Vos, R. A. Le Febre, R. A. G. de Graaff, J. G. Haas-
noot, J. Reedijk, J. Am. Chem. Soc. 1983, 105, 1683.
[19] Y. Garcia, P. Guionneau, G. Bravic, D. Chasseau, J. A. How-
ard, O. Kahn, V. Ksenofontov, S. Reiman, P. Gütlich, Eur. J.
Inorg. Chem. 2000, 1531.
[20] Y. Garcia, F. Robert, A. D. Naik, G. Zhou, B. Tinant, K. Rob-
eyns, S. Michotte, L. Piraux, J. Am. Chem. Soc. 2011, 133,
15850.
[Fe2(Hsaltrz)5(NCS)4]·2MeOH (7): Single crystals were prepared in
a H-shaped tube by slow diffusion. A solution of Fe(ClO4)2·6(H2O)
(128 mg, 0.50 mmol), NaNCS (81 mg, 1.0 mmol) and ascorbic acid
(5 mg) in MeOH (3 mL) was placed in one arm of the tube and a
solution of Hsaltrz (282 mg, 1.5 mmol) in MeOH (3 mL) was
placed in the other arm. The remainder of the tube was carefully
filled with neat MeOH and over a period of 2 weeks yellow crystals
of 7 formed.
[Fe3(Hsaltrz)6(H2O)2(EtOH)4](ClO4)6·2(EtOH) (8): Single crystals
were prepared in a H-shaped tube by slow diffusion. A solution of
Fe(ClO4)2·6(H2O) (128 mg, 0.50 mmol) and ascorbic acid (5 mg) in
of EtOH (3 mL) was placed in one arm of the tube and a solution
of Hsaltrz (94 mg, 0.5 mmol) in EtOH (3 mL) was placed in the
other arm. The remainder of the tube was carefully filled with neat
methanol and over a period of 2 weeks colorless crystals of 8
formed.
Supporting Information (see footnote on the first page of this arti-
cle): Powder X-ray diffraction, crystallographic information, and
thermogravimetric analyses.
[21] A. P. Railliet, A. D. Naik, A. Rotaru, J. Marchand-Brynaert,
Y. Garcia, Hyperfine Interact. 2012, 205, 51.
Eur. J. Inorg. Chem. 2013, 803–812
811
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim